Salmonella Infection Upregulates the Leaky Protein Claudin-2 in Intestinal Epithelial Cells

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Zhang, Yong Guo ^a   Wu, Shaoping ^a   Xia, Yinglin ^b   Sun, Jun ^a,c  

^a RUSH UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CLAUDIN 2; CLAUDIN 3; CLAUDIN 7; GEFITINIB; MESSENGER RNA; SMALL INTERFERING RNA; STREPTOMYCIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; CELL FUNCTION; COLON CANCER; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; ENTERITIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; INTESTINE INFECTION; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; SALMONELLA; SALMONELLOSIS; SPECIES INVASION;

ANIMALS; CELL LINE; CLAUDIN-2; COLON; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL MUCOSA; MAP KINASE SIGNALING SYSTEM; MICE; PERMEABILITY; SALMONELLA INFECTIONS;

EID: 84874880479     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058606     Document Type: Article

References (32)

1. Chiba H, Osanai M, Murata M, Kojima T, Sawada N, (2008) Transmembrane proteins of tight junctions. Biochim Biophys Acta 1778: 588-600.
2. Zeissig S, Burgel N, Gunzel D, Richter J, Mankertz J, et al. (2007) Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56: 61-72.
3. Christakos S, Dhawan P, Ajibade D, Benn BS, Feng J, et al. (2010) Mechanisms involved in vitamin D mediated intestinal calcium absorption and in non-classical actions of vitamin D. J Steroid Biochem Mol Biol. 121: 183-187.
4. Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR, (2008) Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest 88: 1110-1120.
5. Dhawan P, Ahmad R, Chaturvedi R, Smith JJ, Midha R, et al. (2011) Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation. Oncogene 30: 3234-3247.
6. Buchert M, Papin M, Bonnans C, Darido C, Raye WS, et al. (2010) Symplekin promotes tumorigenicity by up-regulating claudin-2 expression. Proc Natl Acad Sci U S A 107: 2628-2633.
7. Berkes J, Viswanathan VK, Savkovic SD, Hecht G, (2003) Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52: 439-451.
8. Liao AP, Petrof EO, Kuppireddi S, Zhao Y, Xia Y, et al. (2008) Salmonella type III effector AvrA stabilizes cell tight junctions to inhibit inflammation in intestinal epithelial cells. PLoS One 3: e2369.
9. Ye Z, Petrof EO, Boone D, Claud EC, Sun J, (2007) Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am J Pathol 171: 882-892.
10. Duan Y, Liao AP, Kuppireddi S, Ye Z, Ciancio MJ, et al. (2007) beta-Catenin activity negatively regulates bacteria-induced inflammation. Lab Invest 87: 613-624.
11. Capaldo CT, Koch S, Kwon M, Laur O, Parkos CA, et al. (2011) Tight function zonula occludens-3 regulates cyclin D1-dependent cell proliferation. Mol Biol Cell 22: 1677-1685.
12. Severson EA, Kwon M, Hilgarth RS, Parkos CA, Nusrat A, (2010) Glycogen Synthase Kinase 3 (GSK-3) influences epithelial barrier function by regulating occludin, claudin-1 and E-cadherin expression. Biochem Biophys Res Commun 397: 592-597.
13. Turner JR, Black ED, Ward J, Tse CM, Uchwat FA, et al. (2000) Transepithelial resistance can be regulated by the intestinal brush-border Na(+)/H(+) exchanger NHE3. Am J Physiol Cell Physiol 279: C1918-1924.
14. Turner JR, Rill BK, Carlson SL, Carnes D, Kerner R, et al. (1997) Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol 273: C1378-1385.
15. Takeuchi K, Ito F, (2010) EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors. FEBS J 277: 316-326.
16. Takeuchi K, Shin-ya T, Nishio K, Ito F, (2009) Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase. FEBS J 276: 1255-1265.
17. Shiou SR, Yu Y, Chen S, Ciancio MJ, Petrof EO, et al. (2011) Erythropoietin protects intestinal epithelial barrier function and lowers the incidence of experimental neonatal necrotizing enterocolitis. J Biol Chem 286: 12123-12132.
18. Rosenthal R, Milatz S, Krug SM, Oelrich B, Schulzke JD, et al. (2010) Claudin-2, a component of the tight junction, forms a paracellular water channel. J Cell Sci 123: 1913-1921.
19. Schulzke JD, Fromm M, (2009) Tight junctions: molecular structure meets function. Ann N Y Acad Sci 1165: 1-6.
20. Van Itallie CM, Holmes J, Bridges A, Anderson JM, (2009) Claudin-2-dependent changes in noncharged solute flux are mediated by the extracellular domains and require attachment to the PDZ-scaffold. Ann N Y Acad Sci 1165: 82-87.
21. Holmes JL, Van Itallie CM, Rasmussen JE, Anderson JM, (2006) Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns 6: 581-588.
22. Clark JA, Gan H, Samocha AJ, Fox AC, Buchman TG, et al. (2009) Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis. Am J Physiol Gastrointest Liver Physiol 297: G471-479.
23. Smith AJ, Schacker TW, Reilly CS, Haase AT, (2010) A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infection. J Acquir Immune Defic Syndr 55: 306-315.
24. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, et al. (2008) Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 295: G1025-1034.
25. Hollander D, (1988) Crohn's disease-a permeability disorder of the tight junction? Gut 29: 1621-1624.
26. Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, et al. (2009) Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci 1165: 294-300.
27. Ivanov AI, Nusrat A, Parkos CA (2004) The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novartis Found Symp 263: 115-124; discussion 124-132, 211-118.
28. Arnott ID, Kingstone K, Ghosh S, (2000) Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand J Gastroenterol 35: 1163-1169.
29. Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H, (1993) Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341: 1437-1439.
30. Sun J, Hobert ME, Rao AS, Neish AS, Madara JL, (2004) Bacterial activation of beta-catenin signaling in human epithelia. Am J Physiol Gastrointest Liver Physiol 287: G220-227.
31. Wu S, Liao AP, Xia Y, Li YC, Li JD, et al. (2010) Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol 177: 686-697.
32. Caplan MS, Miller-Catchpole R, Kaup S, Russell T, Lickerman M, et al. (1999) Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 117: 577-583.